Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Andrew Pekosz and Arturo Casadevall.
Connection Strength

0.518
  1. Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma. mBio. 2021 04 20; 12(2).
    View in: PubMed
    Score: 0.059
  2. Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality. J Clin Invest. 2021 04 01; 131(7).
    View in: PubMed
    Score: 0.059
  3. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals. J Clin Invest. 2021 03 01; 131(5).
    View in: PubMed
    Score: 0.058
  4. ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population. Vox Sang. 2021 Aug; 116(7):766-773.
    View in: PubMed
    Score: 0.058
  5. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers. J Clin Microbiol. 2021 01 21; 59(2).
    View in: PubMed
    Score: 0.058
  6. Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma. Open Forum Infect Dis. 2021 Feb; 8(2):ofaa574.
    View in: PubMed
    Score: 0.057
  7. SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors. J Infect Dis. 2020 11 13; 222(12):1974-1984.
    View in: PubMed
    Score: 0.057
  8. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J Clin Invest. 2020 11 02; 130(11):6141-6150.
    View in: PubMed
    Score: 0.057
  9. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 06 01; 130(6):2757-2765.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.